Edward M. Basile

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
4 years
Director since
2023

4 years of board service in total across 1 board, counting each seat separately. Longest: TransMedics Group Inc., 3 years.

3 years ยท Since 2023

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
May 20, 2026 TransMedics Group Inc. Grant or award +2,922 โ€” โ€”
Oct 29, 2025 TransMedics Group Inc. Option exercise +4,142 $0.70 $2,899
Oct 29, 2025 TransMedics Group Inc. Open-market sale โˆ’4,142 $130.45 $540,324
Aug 4, 2025 TransMedics Group Inc. Option exercise +4,143 $0.70 $2,900
Aug 4, 2025 TransMedics Group Inc. Open-market sale โˆ’4,143 $125.51 $519,988
May 27, 2025 TransMedics Group Inc. Option exercise +5,000 $0.70 $3,500
May 27, 2025 TransMedics Group Inc. Open-market sale โˆ’5,000 $126.45 $632,250
May 22, 2025 TransMedics Group Inc. Grant or award +2,134 โ€” โ€”
May 9, 2025 TransMedics Group Inc. Option exercise +6,000 $0.70 $4,200
May 9, 2025 TransMedics Group Inc. Open-market sale โˆ’6,000 $115.63 $693,780
Nov 5, 2024 TransMedics Group Inc. Option exercise +6,750 $28.12 $189,810
Nov 5, 2024 TransMedics Group Inc. Open-market sale โˆ’5,296 $83.35 $441,422
Nov 5, 2024 TransMedics Group Inc. Open-market sale โˆ’1,454 $84.30 $122,572
Aug 6, 2024 TransMedics Group Inc. Option exercise +6,750 $28.12 $189,810
Aug 6, 2024 TransMedics Group Inc. Open-market sale โˆ’1,830 $148.26 $271,316

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.